Oncology News, Insights, Stories by OncoDaily

BiGART 2025
2025-06-17 00:00 - 2025-06-18 00:00 (America/Sao_Paulo) | Helnan Marselis Hotel, Strandvejen 25, Arhus, 8000, Denmark
The BiGART 2025 conference on Biology-Guided Adaptive Radiotherapy will take place in Aarhus, DK on June 17-18, 2025.
The event organized by Acta Oncologica will bring together leading experts in the field of radiotherapy, oncology, and medical physics to discuss the latest advancements in biology-guided adaptive radiotherapy. This approach aims to improve cancer treatment by integrating biological information, such as tumor heterogeneity and molecular profiles, with adaptive radiotherapy techniques to optimize treatment planning and delivery.
The organizing committee, led by Jesper Grau Eriksen, Professor and Consultant at the Dept. of Oncology, Aarhus University Hospital, and Birgitte Offersen, Karen-Lise Garm Spindler, Jens Overgaard, and Morten Høyer, will guide the event, ensuring a comprehensive and forward-looking program. Participants will have the opportunity to engage with experts in the field, discuss recent developments, and explore new frontiers in radiotherapy research.
BiGART 2025 is set to be a major event for professionals involved in radiotherapy and cancer treatment, offering valuable insights into the integration of biology with adaptive radiotherapy for more precise and effective cancer care.
Abstract Submission Opens on February 3rd to March 10th.
Registration Opens on April 10th to May 12.

VMAT and TomoTherapy TBI, TMI and TMLI by ESTRO
2025-06-16 08:00 - 2025-06-17 17:00 (Europe/Amsterdam) | Utrecht, Utrecht, Netherlands
VMAT and TomoTherapy TBI, TMI and TMLI by ESTRO will be held from 16-17 June, 2025 at Utrecht, The Netherlands.
The Myeloablative Total Body Irradiation (TBI) symposium will feature international experts discussing the latest advancements in highly conformal radiotherapy techniques, such as VMAT and TomoTherapy, for haematopoietic stem cell transplantation (HSCT) conditioning. These techniques, including Total Marrow Irradiation (TMI) and Total Marrow and Lymphoid Irradiation (TMLI), aim to optimize treatment outcomes while minimizing toxicity by targeting specific areas like the bone marrow and lymphoid volume.
The symposium will include breakout sessions focused on technical and clinical aspects of VMAT and TomoTherapy planning and treatment. It is aimed at radiation oncologists, medical physicists, radiotherapy technologists, haematologists, and others interested in TBI, TMI, or TMLI.
Registration is open.

Dose Modelling and Verification for External Beam Radiotherapy by ESTRO
2025-06-15 08:00 - 2025-06-19 17:00 (Europe/Vilnius) | Panorama hotel, Seinų g. 4, Vilnius, Vilnius, 01313, Lithuania
Dose Modelling and Verification for External Beam Radiotherapy by ESTRO will be held from June 15-19, 2025 at Vilnius, Lithuania.
The course is aimed at medical physicists and experienced dosimetrists with practical experience in radiotherapy physics and treatment planning systems. It focuses on reviewing external beam radiotherapy physics, multi-source modeling, and dose calculation algorithms. It covers commissioning treatment planning systems, dosimetry equipment, and dose verification methods for advanced external beam therapy.
Course content includes radiation transport physics, Linac head design, patient and phantom characterization, kernel-based and Monte Carlo dose calculation, and radiation detector systems for TPS commissioning. The course also includes monitor unit calculations, commissioning and quality assurance of treatment planning systems, plan QA, and treatment verification using in-vivo dosimetry.
Early Registration deadline: 19 March 2025.

Comprehensive and Practical Brachytherapy by ESTRO
2025-06-14 13:00 - 2025-06-17 12:00 (America/Sao_Paulo) | HF Ipanema Park, R. de Serralves 124, Porto, 4150-702, Portugal
Comprehensive and Practical Brachytherapy by ESTRO 14-18 June, 2025 at Porto, Portugal.

This course is designed for trainees in radiotherapy, radiation oncologists, medical physicists, and radiation therapists (RTTs) who wish to stay updated on the latest advancements in brachytherapy. It serves as a fundamental introduction to the principles of brachytherapy and is highly recommended as a foundation for specialized courses in prostate cancer, gynecological cancer, and advanced medical physics brachytherapy.
The course covers key topics such as the historical evolution of brachytherapy, sources, afterloading systems, imaging, dosimetry, and the essentials of ICRU reports. It also addresses radiobiology, radioprotection, and the organization of a brachytherapy department. Participants will explore technical and dosimetric aspects of interstitial, endoluminal, and endocavitary brachytherapy. Clinical topics include gynecological cancers (cervix, endometrium), head and neck cancers (oral cavity, oropharynx), urological cancers (e.g., prostate seed implants), breast cancer (e.g., APBI), skin, bladder, and pediatric malignancies. The course includes practical examples of treatment planning and exercises for hands-on understanding.
Early Registration deadline: 19 March 2025.

EHA 2025 Congress
2025-06-12 00:00 - 2025-06-15 00:00 (Europe/Helsinki) | Allianz MiCo-Milano Convention Centre, Piazzale Carlo Magno 1 - 20149 Milano (Lombardia), Milan, 20149, Italy
The 30th EHA Congress is scheduled for June 12-15, 2025 at Milan Italy.
It promises to transform the way we engage with hematology. The EHA team has worked hard to redesign the Congress experience, incorporating new, innovative features to enhance your learning journey.
With a stronger emphasis on invited speakers and the addition of a second poster session, the Congress will present the most cutting-edge research in the field. The revised program offers a carefully curated balance of scientific content, reducing the number of parallel sessions to avoid information overload.
EHA2025 aims to provide an unforgettable experience, fostering meaningful connections, inspiring innovation, and driving progress in hematology.

63rd Annual PTCOG Conference
2025-06-02 00:00 - 2025-06-07 00:00 (America/Sao_Paulo) | Hilton Buenos Aires, Av. Macacha Güemes 351, Puerto Madero, Buenos Aires, Argentina
63rd Annual PTCOG Conference will be held from June 2-7, 2025 at Buenos Aires, Argentina.

This conference is particularly significant as it marks the first time that PTCOG is hosting the Annual Conference in South America. The event will be held during an exciting time for the region, coinciding with the opening of Argentina’s first Proton Therapy Centre, symbolizing a pivotal moment in the development of particle therapy in Latin America.
The vibrant city of Buenos Aires, known for its rich cultural heritage, will provide an ideal setting for the conference. PTCOG 63 aims to foster collaboration and knowledge exchange in particle therapy, with a strong focus on expanding access to this advanced treatment. The conference will feature educational sessions, followed by three days of scientific presentations covering a range of topics, including clinical applications, physics, and biology. The theme, “Bridging Borders in Particle Therapy” highlights the importance of global collaboration and the expansion of particle therapy, especially in developing countries. The conference will also include dedicated sessions in Spanish, promoting interaction among Latin American peers and supporting regional cooperation.
In addition to the rich scientific program, PTCOG 63 will offer opportunities for younger generations to engage in leadership roles through the Scholar-in-Training (SIT) Sub-Committee. The conference will also explore new research avenues and funding opportunities for small research projects. With over 4,000 members and more than 100 facilities represented, PTCOG 63 will be a critical event in the ongoing growth and development of particle therapy worldwide. Participants will not only gain valuable insights but will also experience the unique spirit and hospitality of Argentina.
Abstract Submission Deadline is January 7th, 2025.
For Registration, visit here.

Agora 2025: ESTRO Future Leaders Retreat
2025-06-01 08:00 - 2025-06-03 17:00 (Europe/Copenhagen) | Copenhagen, Denmark, Copenhagen, Denmark
Agora 2025: ESTRO Future Leaders Retreat will be held from June 1-3, 2025.
ESTRO will introduce Agora 2025, an initiative designed to support early-career radiotherapy professionals and help advance their careers in the field. Agora 2025 will offer a platform for emerging leaders to collaborate, discuss the challenges in radiation oncology, and ensure that diverse perspectives are included in these discussions. Participants will reflect on societal and health trends impacting the discipline.
In line with ESTRO’s goals, the initiative will foster long-term involvement from these future leaders, guiding them through a shared journey aimed at progressing radiotherapy over the next decade. Early-career professionals will be encouraged to bring their insights and leadership to help shape the field.
Applications are nor open and the deadline is February 10, 2025!

ASCO Annual Meeting 2025
2025-05-30 00:00 - 2025-06-03 00:00 (America/Halifax) | McCormick Place, 2301 S Martin Luther King Dr,, Chicago
ASCO Annual Meeting 2025 will be held from May 30 – June 3, 2025 at Chicago, Illinois.

The 2025 ASCO Annual Meeting will focus on driving cancer research into actionable change, in line with Dr. Robin Zon’s theme Driving Knowledge to Action: Building a Better Future. The program will feature key sessions such as the Plenary Session with groundbreaking abstracts, the Opening Session with the Presidential Address and Karnofsky Award Lecture, and ASCO Voices, which will highlight diverse perspectives in oncology.
Attendees can expect over 450 oral presentations across 24 Oral Abstract Sessions and 24 Rapid Oral Abstract Sessions, along with 13 Clinical Science Symposia. The conference will also host 16 Case-Based Panels, which involve interactive audience participation, and joint sessions with AACR and ESMO. With over 2,700 poster presentations, including Trials in Progress, the event will showcase the latest in cancer research, clinical trials, and treatment innovations.
For Abstract Submission Visit Here

4th Translational Research Conference: Acute Lymphoblastic Leukaemia by ESH
2025-05-22 00:00 - 2025-05-24 00:00 (Europe/Helsinki) | Grand Hotel Malahide, Coast Road Malahide Dublin, Dublin, 20, Ireland
4th Translational Research Conference: Acute Lymphoblastic Leukaemia will be held at Malahide (Dublin), Ireland from May 22-24, 2025.
ESH Translational Research Conference programs are tailored to highlight the latest advancements in basic, clinical, and therapeutic research, with a focus on future developments in the field. These conferences are structured to provide extensive opportunities for in-depth scientific discussions and interactive engagement.
Registered participants gain access to various platforms for informal interactions with top global experts, including ‘Meet the Expert’ sessions and guided ‘Mentored Poster Walks.’
For registration visit here

2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium
2025-05-21 08:00 - 2025-05-22 17:00 (America/Halifax) | MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Houston, United States
2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium will be held from May 21-22, 2025 at Houston, Texas.
The 2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium will bring together global experts to explore the latest advancements in MDS research and treatment. This event focuses on the biological mechanisms of hematopoietic stem cells in both normal and disease states, aiming to deepen understanding and improve therapeutic strategies for MDS.
Attendees will gain insights into cutting-edge diagnostics, molecular findings, and innovative treatment approaches. The symposium fosters collaboration and knowledge exchange to advance progress in managing this complex hematologic malignancy.
Registration is open for the event.

The Evidence-Based Radiation Oncology by ESTRO
2025-05-19 00:00 - 2025-05-23 00:00 (Europe/Madrid) | Seville, Seville, Spain
The Evidence-Based Radiation Oncology course, hosted by ESTRO in Seville, Spain, from May 19-23, 2025, will focus on clinical research, biomedical statistics, and evidence-based radiotherapy.
Participants will learn the core concepts of evidence-based medicine and the methodologies behind clinical research. The course will cover radiation therapy advancements for major tumor sites like breast, prostate, lung, and gynecological cancers, as well as palliative radiation therapy. With a combination of lectures and case discussions, the course will provide opportunities for participants to explore clinical scenarios in small groups and evaluate management options based on the latest research evidence.
Early registration ends on February 19, 2025.

The Advanced Research Technologies for Personalized Medicine
2025-05-18 08:00 - 2025-05-19 17:00 (Asia/Qatar) | Sidra Medical and Research Centre, Al graffa Qatar, Doha,, Doha, Qatar
The Advanced Research Technologies for Personalized Medicine will be held from May 18-19, 2025 at Doha, Qatar.
The Advanced Research Technologies for Personalized Medicine conference will bring together scientists, clinicians, and industry leaders to explore how flow cytometry and optical microscopy are advancing precision medicine. Under the theme “Innovation in Flow Cytometry and Optical Microscopy,” the event will highlight breakthroughs in disease diagnosis, biomarker discovery, and targeted therapies. Topics will include cancer biology, immunology, digital pathology, spatial proteomics, and single-cell analysis.
In addition to expert-led sessions and technology showcases, a hands-on workshop will take place from 20–22 May, 2025, offering participants practical experience with cutting-edge tools in flow cytometry and optical microscopy. This workshop is designed to build essential technical skills and enhance understanding of data acquisition, analysis, and interpretation.
Registration is open for the event.

ESMO Breast Cancer Congress 2025
2025-05-14 11:00 - 2025-05-17 13:00 (Europe/Helsinki) | ICM-International Congress Center of the Munich Messe, Am Messesee 2, Munich, 81829, Germany
The ESMO Breast Cancer Congress 2025 will take place in Munich, Germany, on May 14-17, 2025, with an online option available through a dedicated virtual platform. It is organized by the European Society For Medical Oncology.
This focused event will bring together international experts to explore the latest innovations, discuss cutting-edge treatments, and collaborate on strategies to improve patient outcomes in breast cancer.
Don’t miss the opportunity to be part of this important gathering.
Abstract submission deadline is 11 February 2025.
Read more featuring ESMO at OncoDaily.com.

The 15th CCI Europe Conference
2025-05-14 08:00 - 2025-05-17 17:00 (America/Halifax) | Budapest, Budapest, Hungary
The 15th CCI Europe Conference will be held face-to-face from May 14 to 17, 2025, in Budapest, Hungary.
Organized in partnership with SIOP Europe and as part of the SIOPE’s 6th Annual Meeting of the European Society for Paediatric Oncology, this event promises to be a key gathering for the CCI Europe community. The sessions on May 17 will be exclusively for CCI Europe members, emphasizing the organization’s commitment to continuing education and active participation.
In recognition of financial challenges faced by some member organizations, CCI Europe has allocated a limited amount of funding to support delegates from parent organizations. Additionally, the Twinning Programme will provide stipends for members, particularly from low-income countries, to encourage the attendance of parents, survivors, and professionals from CCI member organizations.
Registration is open for the event.

SIOP Europe Annual Meeting 2025
2025-05-12 08:00 - 2025-05-16 17:00 UTC | Budapest, Budapest, Hungary
SIOP Europe Annual Meeting 2025 will take place in Budapest, Hungary on 12-16 May 2025.
The SIOPE Annual Meeting offers a unique format that blends interactive workshops, forums, and novel session formats, fostering collaboration among European and international clinical and research groups. The event will feature 18 European Clinical Trial Groups, each specializing in specific tumour types, who will hold both open and joint sessions to share best practices in research.
The meeting is designed to allow liquid and solid tumour groups to meet separately, with joint sessions on the middle day to promote cross-tumour learning and networking. Plenary sessions will cover a range of important topics, including recent clinical trial outcomes, advances in diagnosis and treatment, and the use of artificial intelligence in pediatric oncology.
Additional sessions will address drug safety, radiation oncology, epidemiology, data protection, and patient communication, with significant contributions from long-time partner CCI Europe on issues such as patient involvement and informed consent. This diverse program aims to advance scientific knowledge and foster collaboration across various aspects of childhood cancer care.
For Registration Visit Here.

The 14th I-BFM Biennial Childhood Leukemia and Lymphoma Symposium
2025-05-10 13:00 - 2025-05-11 18:00 (Europe/Budapest) | Budapest, Hungary, Budapest, Hungary
The 14th I-BFM Biennial Childhood Leukemia and Lymphoma Symposium (CLLS) will be held in Budapest, Hungary, on May 10-11, 2025.
This prestigious event has become a cornerstone for the advancement of knowledge and collaboration in the field of childhood hematological malignancies. It provides a unique platform for fellows, researchers, and junior faculty to present and discuss the latest groundbreaking findings in the diagnosis, treatment, and molecular genetics of acute lymphoblastic leukemia (ALL), non-Hodgkin’s lymphoma (NHL), and myeloid disorders.
The symposium will feature a series of keynote discussions on critical topics, including the role of molecular genetics in diagnosing and treating juvenile myelomonocytic leukemia (JMML), the necessity of intensive chemotherapy for curing primary ALL, and the importance of sequencing leukemia patients for cancer predisposition genes. Other significant topics include how molecular genetics complement the staging of pediatric NHL and lessons learned from real-world data on CAR-T cell therapy from the GoCART study. This event promises to foster collaboration and inspire new research directions in the treatment of childhood blood cancers.
Registration is open for the event.
Abstract Submission deadline is March 12, 2025.

Masterclass in Clinical Oncology - Summer edition
2025-05-09 00:00 - 2025-05-14 00:00 (Europe/Helsinki)
Masterclass in Clinical Oncology – Summer edition will be held from May 9th to June 24th, 2025.
The ESO Masterclass is an intensive, clinically focused event designed for medical and clinical oncologists with 3-4 years of experience in oncology, aiming to deepen their training in the treatment of tumors from a multidisciplinary perspective. The program offers participants exposure to a comprehensive range of issues in clinical oncology, complemented by practice-oriented training.
The Masterclass is structured into:

Plenary lectures: Covering state-of-the-art clinical treatments, referencing clinical guidelines, and delivered by renowned international faculty.
Interactive workshops: Designed to engage participants in practical discussions and learning.
Clinical case presentations/tumor board simulations: Each participant presents and discusses their cases with an international panel of top experts specializing in various tumor types.

The Masterclass consists of two educational components:

Pre-recorded online lectures: Available from 9 May 2025.
In-person event: Scheduled from 21-24 June 2025.

International Symposium on Minimal Residual Cancer 2025
2025-05-07 08:00 - 2025-05-09 17:00 (Europe/Paris) | Hyatt Regency Nice Palais de la Méditerranée, 13, Promenade des Anglais, Nice, 06000, France
International Symposium on Minimal Residual Cancer 2025 will be held from May 7-9, 2025 at Nice, France.
The upcoming international meeting is a fantastic opportunity to gather for three days to discuss the latest advancements in the use of liquid biopsies in cancer patients. This event will focus on clinical applications, specifically how liquid biopsy can guide treatment decisions in immuno-oncology and targeted therapies. Special sessions will explore new approaches in minimal residual disease detection, early cancer detection and screening, as well as monitoring disease progression through blood samples to track resistance mechanisms to various treatments.
The congress will also feature fundamental and translational presentations on different liquid biopsy components, including Circulating Tumor Cells, exosomes, miRNA, and circulating free DNA. Additionally, the future potential of liquid biopsy will be discussed. Supported by the European Liquid Biopsy Society (ELBS) and the Institute RespirERA in Nice, the meeting will include plenary sessions led by international experts in liquid biopsy and cancer biology. The ISMRC will also offer young investigators a platform to present their work, with selected oral and poster presentations receiving awards for excellence.

The 18th International Congress on MDS
2025-05-07 00:00 - 2025-05-10 00:00 (America/Sao_Paulo) | De Doelen ICC Rotterdam, Karel Doormanstraat 223, Rotterdam, De, 3076, Netherlands
The 18th International Congress on MDS will be held at Rotterdam, The Netherlands from May 7-10, 2025.
This congress will bring together leading international specialists to share their expertise and discuss the latest breakthroughs in MDS research, including basic and translational research, as well as advancements in diagnosis, prognosis, and management of MDS.
Throughout the event, attendees will have the unique opportunity to explore new treatments, innovative diagnostic techniques, and evolving therapeutic strategies for MDS. It will also be a chance to hear from renowned researchers, engage in insightful discussions, and network with fellow professionals from around the world.
Deadline for the Abstract Submission is January 14th, 2025.

ESTRO 2025: Your Ultimate Guide to the World’s Leading Radiation Oncology Congress
2025-05-02 - 2025-05-06 | Messe Wien Exhibition & Congress Center, Vienna, Austria
ESTRO 2025 (European Society for Radiotherapy and Oncology) is the premier global event for radiation oncology professionals, taking place from May 2-6, 2025, at the Messe Wien Exhibition & Congress Center in Vienna, Austria. This prestigious congress brings together experts from around the world to discuss transformative innovations in radiotherapy, explore the latest clinical research, and foster collaborations to enhance multidisciplinary cancer care. Whether you’re a radiation oncologist, physicist, or researcher, ESTRO 2025 provides unparalleled opportunities for networking, education, and professional growth, offering specialized tracks for young professionals and showcasing the most cutting-edge radiotherapy technology.
Submit your abstract to present at the leading radiation oncology event and join the conversation about the future of cancer treatment.
Where is ESTRO 2025?
ESTRO 2025 is a major event in the field of radiation oncology. It will be held in Vienna, Austria, from May 2 to 6, 2025, at the Messe Wien Exhibition & Congress Center. This congress gathers the global radiation oncology community for five days of cutting-edge research, collaboration, and learning opportunities, and will feature discussions, sessions, and presentations led by top experts in the field.
Important Dates for ESTRO 2025 Abstract Submissions
Abstract Submission Opens: September 2, 2024
Abstract Submission Deadline: November 20, 2024
Late-Breaking Abstract Deadline: March 19, 2025
Acceptance Notification: Mid-February 2025
All abstracts are peer-reviewed, and the best submissions will be celebrated in dedicated sessions, including a joint session with The Lancet Oncology and Radiotherapy & Oncology (The Green Journal). Don’t miss your chance to be part of the most prestigious congress in the field.

Who are the Key People at ESTRO 2025?
The Scientific Programme Committee is chaired by Matthias Guckenberger (CH), the ESTRO 2025 Chair and President. Other leaders include:

Frank-André Siebert (DE), Chair of Brachytherapy
Icro Meattini (IT), Chair of Clinical Radiotherapy
Christian Richter (DE), Chair of Radiation Physics
Monica Mangoni (IT), Chair of Radiobiology
Maeve Kearney (IE), Chair of Radiation Therapy

The programme also includes special Young Track chairs, Dylan Callens (BE) and Daniel Portik (RO), who focus on supporting those starting out in radiation oncology.
What Sessions Will Be Held at ESTRO 2025?
ESTRO 2025’s programme theme is Transformative Innovation Through Partnership. The congress will cover a variety of disciplines with a focus on multidisciplinary cancer care. The Young Track offers educational sessions specifically designed for professionals at the early stages of their careers. Other sessions include:

Panel discussions
Pitch sessions
Debates
Symposia
Teaching lectures

Joint sessions with partner associations are also included, giving delegates access to a broader community. The congress will showcase the latest clinical trials, cutting-edge research, and technological advances.
What is the Venue for ESTRO 2025?
The congress will take place at the Messe Wien Exhibition & Congress Center in Vienna, Austria. This state-of-the-art venue will also host Europe’s largest industry exhibition in radiation oncology, offering unparalleled opportunities to network with industry leaders and explore the latest innovations in the field.

What is the Cost of Attending ESTRO 2025?
ESTRO members enjoy a reduced registration fee. Early bird rates are available until January 22, 2025. Special rates are also offered for students and participants from emerging countries. To register as a student, you must be an ESTRO member and provide a valid student card. All participants need to register using an individual email address to receive their unique login details for the ESTRO 2025 apps.

source: ESTRO.org
What Are the Benefits of Submitting an Abstract to ESTRO 2025?
Submitting an abstract to ESTRO 2025 gives you the opportunity to:

Present your research at the leading radiation oncology congress.
Gain visibility through mini-oral sessions and poster discussions.
Have your work considered for joint publication in Radiotherapy & Oncology or The Lancet Oncology.
Engage with experts and peers through interactive sessions and debates.

How Can You Register for ESTRO 2025?
You can register online on the ESTRO website, with secure payment options available via credit or debit card. For group registration, you can contact the ESTRO office directly for support.
What Opportunities Are Available for Young Professionals at ESTRO 2025?
ESTRO 2025 places a strong emphasis on nurturing the next generation of radiation oncology professionals through its dedicated Young Track. This track is specifically designed for those in the early stages of their careers, offering tailored educational sessions, networking opportunities, and mentorship from leaders in the field. The Young Track chairs, Dylan Callens (BE) and Daniel Portik (RO), ensure that young professionals have access to high-quality learning experiences, including hands-on workshops, pitch sessions, and debates. These sessions provide invaluable insights and practical knowledge to help young professionals excel in the fast-evolving field of radiation oncology.
What Should You Know About ESTRO 2025 Media and Communication Policies?
ESTRO welcomes media professionals to the congress. Press registration is free for journalists, and embargoes for abstract reporting are lifted one month before the congress. For social media, the official hashtag is #ESTRO25, and participants are encouraged to share their experiences while respecting intellectual property and privacy guidelines.
Why Should You Attend ESTRO 2025?
ESTRO 2025 is the key event for radiation oncology professionals. It offers a platform for learning, networking, and innovation, with a special focus on breakthrough research, partnerships, and technological advances in the field. Whether you’re early in your career or an experienced professional, the congress provides something for everyone, from interactive sessions to industry exhibitions.

Where Is ESTRO 2025 Held?
ESTRO 2025 will be hosted at the Messe Wien Exhibition & Congress Center in Vienna, Austria. This modern venue offers state-of-the-art facilities, ensuring a comfortable and efficient environment for both the congress and the large-scale industry exhibition. The center is located in the heart of Vienna, easily accessible by public transport, and provides all the amenities required for a successful international event.
Discover Vienna: The City of Culture and History
Vienna, Austria’s capital, is renowned for its rich cultural heritage, stunning architecture, and vibrant arts scene. From the historic Hofburg Palace to the majestic St. Stephen’s Cathedral, the city is full of iconic landmarks that reflect its imperial past. As a hub of classical music, you can visit famous sites such as the Vienna State Opera or explore the works of Mozart, Beethoven, and Strauss in the city’s many museums and concert halls.
What Are the Top Hotels Near the ESTRO 2025 Venue?

Hilton Vienna Danube Waterfront – Located along the river, this hotel offers beautiful views, spacious rooms, and easy access to the congress venue.
Hotel Messe Prater Wien – Just a few minutes’ walk from Messe Wien, this modern hotel provides comfort and convenience.
Austria Trend Hotel Messe Wien – This hotel offers contemporary accommodations right next to the congress center.
Motel One Wien-Prater – Known for its stylish yet affordable rooms, this hotel is a popular choice for travelers on a budget, with close proximity to the venue.

Where to Go: Top Bars in Vienna

Kleinod – A stylish cocktail bar offering a wide range of creative drinks in an intimate atmosphere.
Loos American Bar – Designed by the famous architect Adolf Loos, this small bar is a hidden gem, perfect for sipping a well-crafted cocktail.
If Dogs Run Free – A trendy, laid-back bar with an impressive cocktail menu and a cool, industrial vibe.
The Sign Lounge – Known for its innovative and visually stunning cocktails, this bar is a must-visit for mixology enthusiasts.

Where to Eat: Top Restaurants in Vienna

Steirereck – A Michelin-starred restaurant offering modern Austrian cuisine with an emphasis on fresh, local ingredients.
Figlmüller – Famous for serving one of the best Wiener Schnitzels in Vienna, this traditional eatery is a must-try for local flavors.
Plachutta – Known for its Tafelspitz (boiled beef), this restaurant is perfect for those looking to experience authentic Austrian cuisine.
Fabios – A sleek and upscale restaurant offering a mix of Mediterranean and Austrian dishes in a chic, modern setting.

Practical Tips for ESTRO 2025 Participants

Public Transport: Vienna boasts a highly efficient public transportation system, including the U-Bahn (subway), trams, and buses. A great option for visitors is the Vienna City Card, which offers unlimited travel on public transport and discounts at numerous museums and attractions.
Vienna International Airport (VIE): The airport is well-connected to the city center via the City Airport Train (CAT), which takes only 16 minutes, and by buses. Both options provide a smooth and quick journey to your accommodation or the congress venue.
Weather: In early May, Vienna experiences mild spring weather. Expect temperatures ranging from 12°C to 20°C (54°F to 68°F). It’s advisable to bring a light jacket or layers, as evenings can be cooler.
Currency: Vienna uses the Euro (€). Credit cards are widely accepted, but it’s always handy to have some cash for smaller establishments or public transport tickets.
Language: German is the official language, but most people in Vienna, especially in tourist areas, speak English.

Read More About ESTRO

POEM 2025
2025-05-01 00:00 - 2025-05-03 00:00 (Atlantic/Azores) | Amman, Amman, 11120, Jordan
Pediatric Oncology East and Mediterranean (POEM 2025) will be held from May 1-3, 2025 at Amman, Jordan.
The Pediatric Oncology East and Mediterranean (POEM) Group was established in 2013 as a cooperative platform aimed at uniting healthcare professionals, physicians, and researchers from institutions across the East and Mediterranean regions. The group’s mission is to foster collaboration by sharing expertise, initiating joint clinical trials, and developing common strategies to optimize pediatric oncology care. By facilitating the exchange of knowledge and resources, POEM seeks to address the unique challenges faced by pediatric cancer patients in these regions and bridge the gaps in healthcare access and treatment disparities.
In addition to promoting cooperation in clinical research, the POEM Group focuses on capacity-building efforts, including training healthcare providers, raising awareness, and establishing pediatric oncology centers in underserved areas. The group’s work is essential in ensuring that children with cancer, regardless of their location or available resources, receive the best possible care. Through these initiatives, POEM aims to improve diagnosis, treatment outcomes, and long-term care for pediatric oncology patients, contributing to the overall global effort to enhance survival rates and quality of life for children with cancer in the region.
More details will be coming soon, Stay Tuned.

The COA Conference 2025
2025-04-29 06:30 - 2025-04-30 15:30 (America/Halifax) | Walt Disney Dolphin Hotel, 1500 Epcot Resorts Blvd, Lake Buena Vista, Orlando, FL, 32830, United States
The COA Conference 2025 will be held from April 29-30, 2025 at Walt Disney Dolphin Hotel, Orlando, Florida.
The annual Community Oncology Conference is designed to empower independent community oncology professionals in advocating for a better future for cancer care. It brings together attendees committed to ensuring that patients have access to high-quality, affordable, and cutting-edge cancer care in their local communities.
Organized by frontline professionals in community oncology, the conference focuses on improving patient care, growing practices, and advocating for a strong future. Sessions include topics like the management of Acute Myeloid Leukemia, pharmacist-led hyperglycemia management in HR+ breast cancer, and comprehensive approaches for treating relapsed/refractory diffuse large B-cell lymphoma in community oncology practices.
On-site registration for the event will open at 6:30 a.m. on both Tuesday, April 29, and Wednesday, April 30, 2025. Online registration remains open and available at any time.

Ca-PRI 2025
2025-04-29 00:00 - 2025-04-30 00:00 (Europe/Helsinki) | The Lowry Hotel, 50 Dearmans Place, Chapel Wharf, Salford M3 5LH, Manchester, United Kingdom
Ca-PRI 2025 is taking place in Manchester, from April 29-30.
Ca-PRI 2025 is organized by Manchester Cancer Research Centre and will be offering an exciting opportunity to explore the latest advancements in primary care research. Over the course of two days, the event will focus on key themes such as innovations in cancer care, addressing cancer inequalities, and promoting interdisciplinary approaches to care.
Attendees will also have the opportunity to network with leading primary care professionals and researchers from around the world, fostering collaboration and sharing insights in this vital field.

The 7th Emirates Pediatric Hematology and Oncology Conference
2025-04-26 08:00 - 2025-04-27 17:00 (America/Halifax) | Dusit Thani Hotel, Abu Dhabi, 925 Sultan Bin Zayed The First Street, Abu Dhabi, 00000, United Arab Emirates
The 7th Emirates Pediatric Hematology and Oncology Conference will be held from April 26-27, 2025 at Abu Dhabi, UAE.
The 7th Emirates Pediatric Hematology and Oncology Conference (EPHOC) will focus on the diagnosis and management of common hematological and oncological conditions in children. The conference is designed for healthcare professionals, including pediatricians, subspecialists, residents, fellows, and family physicians.
Experts from around the world will share insights and strategies to improve care for young patients with cancer and blood disorders, empowering attendees with the latest knowledge to enhance treatment outcomes.
Registration is open for the event.
Abstract Submission is also open.

AACR Annual Meeting 2025
2025-04-25 08:00 - 2025-04-30 17:00 (America/New_York) | McCormick Place Convention Center, 2301 S Martin Luther King Dr, Chicago, Illionis, United States
The AACR Annual Meeting 2025 is set to be held at the McCormick Place Convention Center in Chicago, Illinois on April 25-30. It is organized by the American Association for Cancer Research.
This event is a key gathering for the cancer research community, bringing together scientists, clinicians, patients, survivors, and advocates to share the latest advancements in cancer science and medicine.
The meeting will cover a wide range of topics, including population science, cancer biology, clinical studies, and survivorship. You’ll hear from top experts and engage with the best minds in cancer research from around the globe.
Don’t miss this opportunity to connect, learn, and be inspired. Mark your calendars and get ready to join!

EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary sAML
2025-04-25 08:00 - 2025-04-26 17:00 (Europe/Berlin) | Berlin, Berlin, Germany
EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary AMLs will be held April 25-26, 2025 at Berlin, Germany.
The EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary Acute Myeloid Leukemias (sAML) will focus on therapy-related AML and AML evolving from previous myeloid diseases, such as MDS or MFS/MPN. Key topics will include clonal hematopoiesis, clonal evolution mechanisms, and special clinical situations.
The program will cover pathogenetic mechanisms, including susceptibility factors like molecular lesions, the bone marrow microenvironment, and the impact of drugs. Special topics include sAML following childhood malignancies, gene therapy, CAR-T cell therapy, and AML of donor origin in allogeneic stem cell transplantation. The meeting will feature leading experts in sAML molecular characterization, disease diagnosis, management, and treatment. The event will be chaired by K. Döhner, P. Vyas, and M.T. Voso.
Registration is open.

Acute Lymphoblastic Leukemia - Strategies to reduce relapse risk in low resource settings webinar by SIOP
2025-04-24 19:00 - 20:30 (Asia/Yerevan)
Acute Lymphoblastic Leukemia- Strategies to reduce relapse risk in low resource settings webinar by SIOP will be held on April 24, 2025, Virtually.
The SIOP Global Health Network (GHN) is hosting an educational session through its new initiative, the Disease-Specific Portal for Learning and Networking (DiSPLeN). This platform offers SIOP members valuable learning opportunities focused on various aspects of pediatric cancer care, including case discussions, diagnostic and referral pathways, access to care, and advanced therapies. The initiative supports the goals of the WHO Global Initiative for Childhood Cancer, particularly its focus on the six indexed cancers.
This session will be moderated by Jelena Lazic (Serbia) and Kirril Kirgizov (Russia), featuring a case presentation by Jovana Kostadinovic (Serbia). Invited speakers Martin Schrappe (Germany) and Cesar Nunez (USA) will provide expert commentary and insights. Through DiSPLeN, SIOP GHN aims to foster collaborative learning and strengthen global pediatric oncology care.
Registration is open for the event.

The BSMO Webinar on Toxicity management with ADCs in solid tumours
2025-04-24 19:00 - 20:30 (America/Halifax)
The BSMO Webinar on Toxicity management with ADCs in solid tumours will be held at April 24, 2025.
The BSMO Webinar on Toxicity Management with ADCs in Solid Tumours will focus on the management of various toxicities associated with Antibody-Drug Conjugates (ADCs) in solid tumours, such as breast, lung, and gastric cancer. The Webinar will be chaired by Evandro de Azambuja and Kevin Punie.
The topics covered will include the management of haematological toxicities caused by ADCs, as well as strategies for addressing gastro-intestinal toxicities related to ADC treatments. The webinar will also focus on preventing and managing interstitial lung disease (ILD) caused by ADCs. Additionally, it will discuss approaches for dealing with common side effects such as fatigue and alopecia.
Registration is open.

The ENTERO Policy Event by Digestive Cancers Europe
2025-04-24 09:30 - 12:00 (Europe/Brussels) | European Parliament, Brussels, Rue Wiertz 60, 1050 Ixelles, Brussels, Belgium
The ENTERO Policy Event by Digestive Cancers Europe will be held on April 24th, 2025 at the European Parliament, Belgium.
The ENTERO Policy Event, organized by Digestive Cancers Europe (DiCE) and co-hosted by Romana Jerkovic and Vytenis Povilas Andriukaitis, will address the rise of early-age onset digestive cancers affecting individuals under 50. The event aims to raise awareness, improve early detection, and enhance care through discussions with patients, healthcare professionals, researchers, and policymakers. Prof. Eric Van Cutsem and Vytenis Povilas Andriukaitis will deliver the closing remarks.
Registration is open for the event.

From policy frameworks to real-world implementation: a call to action by SPCC
2025-04-16 08:00 - 17:00 (America/Halifax)
From policy frameworks to real-world implementation: a call to action by SPCC will be held on April 16, 2025, Virtually.
This comprehensive course includes three educational modules and a live interactive webinar, focusing on key opportunities, challenges, and best practices in Data Policy and Management in Cancer Care.
Expert speakers for the course include Pisani Eduardo, Presti Pietro, Garcia-Foncillas López Jesús, Hickey Matt, and Saunders Christobel, who will share their insights on navigating the complexities of cancer care, optimizing data management, and improving patient outcomes through innovative strategies. This training provides a valuable opportunity for professionals to enhance their skills and understanding in this critical area of cancer care.
